We are live on ! Find out more

1,411 hedge funds and large institutions have $39.3B invested in MetLife in 2025 Q2 according to their latest regulatory filings, with 125 funds opening new positions, 563 increasing their positions, 505 reducing their positions, and 107 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 125 | Existing positions closed: 107

11% more repeat investments, than reductions

Existing positions increased: 563 | Existing positions reduced: 505

0% more funds holding

Funds holding: 1,4111,411 (0)

0.02% less ownership

Funds ownership: 72.89%72.87% (-0.02%)

1% less capital invested

Capital invested by funds: $39.8B → $39.3B (-$500M)

30% less call options, than puts

Call options by funds: $554M | Put options by funds: $785M

31% less funds holding in top 10

Funds holding in top 10: 139 (-4)

Holders
1,411
Holders Change
Holders Change %
0%
% of All Funds
18.53%
Holding in Top 10
9
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-30.77%
% of All Funds
0.12%
New
125
Increased
563
Reduced
505
Closed
107
Calls
$554M
Puts
$785M
Net Calls
-$232M
Net Calls Change
+$213M

MET Hedge Fund Activity: Q2 2025 in Review

1,411 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in MetLife (MET) for Q2 2025, worth a combined $39.3B — down 1.3% from $39.8B a quarter earlier.

Buyers outnumbered sellers: 125 funds opened new MET positions and 107 closed out — a net gain of 18 holders — while 563 added to existing stakes and 505 trimmed.

The largest buyer was Amundi, adding an estimated $99.7M. The largest seller was T. Rowe Price Associates, cutting an estimated $483M.

  • 1,411 institutional investors held MetLife (MET) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $39.3B of MetLife stock for Q2 2025, down 1.3% quarter-over-quarter.
  • 125 funds opened new MetLife positions in Q2 2025 and 107 closed out, a net change of +18 holders.
  • The largest MetLife buyer in Q2 2025 was Amundi, an estimated $99.7M added.
  • The largest MetLife seller in Q2 2025 was T. Rowe Price Associates, an estimated $483M sold.

Based on aggregated 13F filings for Q2 2025.